Revenue
2023
2024
2025
2026
Cellyan Biotechnology Co., Ltd (HKPD)
Price$0.1276Cached quote
Net income
2023
2024
2025
2026
Free cash flow
2023
2024
2025
2026
Total cash / debt
CashTotal debt
2023
2024
2025
2026
Financial statements
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Revenue | $13.4M | $20.3M | $16.7M | $12.6M |
| Gross profit | $1.4M | $2.4M | $3.6M | $2.7M |
| Gross margin | 10.32% | 11.89% | 21.32% | 21.81% |
| Operating expenses | $2.4M | $4.7M | $5.5M | $4.5M |
| Operating income | −$1.0M | −$2.3M | −$2.0M | −$1.8M |
| Operating margin | −7.47% | −11.25% | −11.71% | −14.27% |
| EBITDA | −$307,331 | −$2.2M | −$1.9M | −$1.7M |
| EBITDA margin | −2.29% | −10.92% | −11.36% | −13.68% |
| Net income | −$1.1M | −$27,056 | $1.3M | $998,196 |
| Net profit margin | −8.46% | −0.13% | 7.97% | 7.95% |
| Basic EPSper basic share | — | -$0.00 | $0.18 | $0.15 |
| Diluted EPSper diluted share | — | -$0.00 | $0.18 | $0.15 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
StoneX Group Inc. | 102.31K |
JANE STREET GROUP, LLC | 49.09K |
HRT FINANCIAL LP | 41.82K |
XTX Topco Ltd | 38.93K |
Clear Street Group Inc. | 12.02K |
UBS Group AG | 1.08K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data